In order to scale up prevention and treatment, and increased investment, to protect vulnerable people from Malaria, WHO ...
LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will ass...
Sandoz, a Novartis division, and Pear Therapeutics, Inc., has announced the commercial launch of reSET for patients with...
Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...
Forbion, a leading European life science venture capital firm has announced that it has led a Series B financing round o...
The World Health Organization (WHO) is shifting its focus towards active screening of girls and women of childbearing ag...
Agilent Technologies Inc. has announced the opening of a new, purpose-built extension to its Little Island, Cork facilit...
Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes...
Vyera Pharmaceuticals, LLC has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...
Singapore - Citing the sharp rise in youth use of e-cigarettes, FDA Commissioner Scott Gottlieb, M.D. announces&nbs...
Singapore - Aimed at trimming annual operating expenses by $100M - 150M and boosting performance, Boston Scientific will...
ADC Biotechnology (ADC Bio), announces that it has secured additional funding of £2.5 million from existing invest...
Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...
Singapore - A California jury clears Johnson & Johnson of liability in a case involving a woman who alleged tha...
Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...
Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimil...
Grunenthal has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ...
Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like m...
